Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
,
Fadilah NIM, Rahman MBA, Yusof LM, Mustapha NM, Ahmad H
You may not place drug or supplement advertising adjacent to our story
Patients using medications such as neuroleptics, antidepressants, mood stabilizers, and others within specified time frames before screening were also disqualified [1]
Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Shimomura I, Watada H (2016) Alogliptin, a dipeptidyl peptidase 4 inhibitor, prevents the progression of carotid atherosclerosis in patients with type 2 diabetes: the study of preventive effects of alogliptin on diabetic atherosclerosis (SPEAD-A)
The Type 2 Diabetes Mellitus sub-segment dominates due to the high prevalence of diabetes cases in India, which has seen a sharp rise, with over 77 million people affected
US$ 29.15
US$ 22.62
US$ 20.20
US$ 27.54
US$ 24.75
US$ 23.54
US$ 26.35
US$ 23.01
US$ 23.19
